UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
Corify Care Achieves CE Mark Certification for ACORYS MAPPING SYSTEM

We are thrilled to share some exciting news with you: Corify Care has achieved CE Mark certification under the Medical Device Regulation...

Read More »
Corify will be at Atrial Signals Congress 2024

We are pleased to announce that Corify Care will be represented at the upcoming Atrial Signals Congress taking place this Friday, June...

Read More »
Invited talks on ECGI at the HRS2024

🔬 hashtag#Innovative hashtag#Cardiology hashtag#Research: Upcoming Presentations at hashtag#HRS2024 by Corify Care and COR group – ITACA🌟 This week, we’re thrilled to share...

Read More »